---
figid: PMC6901085__nihms-1541390-f0001
figtitle: Representation of AKT pathway and downstream effectors
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC6901085
filename: nihms-1541390-f0001.jpg
figlink: pmc/articles/PMC6901085/figure/F1/
number: F1
caption: Representation of AKT pathway and downstream effectors. Shown are the key
  molecular targets involved in AKT signaling. Upon growth factor binding to receptor
  tyrosine kinase (RTK), phosphoinositol bisphosphate (PIP2) is converted to phosphoinositol
  trisphosphate (PIP3), which recruits AKT and phosphoinositide-dependent kinase-1
  (PDK1) to the plasma membrane by binding the PH domain to membrane lipids. PDK1
  and mammalian target of rapamycin complex 2 (mTORC2) phosphorylate AKT, resulting
  in full activation of AKT. Phosphatase and tensin homolog (PTEN) and PH domain leucine-rich-protein
  phosphatase (PHLPP) negatively regulate AKT through dephosphorylation of PIP3 and
  AKT (serine-473 residue) respectively. Once activated AKT phosphorylates and inhibits
  the proline-rich AKT substrate of 40 kDa (PRAS40) and tuberous sclerosis complex
  1 and 2 (TSC1 and TSC2) to promote protein synthesis. AKT blocks apoptosis through
  inhibition of BCL-2-antagonist of cell death (BAD), BCL-2-like protein 11 (BIM),
  and forkhead box protein O1 (FoxO1). It also phosphorylates MDM2, resulting in p53
  degradation. AKT prevents cell cycle arrest and cyclin D1 degradation by phosphorylating
  and inhibiting cyclin dependent kinase inhibitor p27, and glycogen synthase kinase
  3β (GSK3β).
papertitle: Targeting AKT for cancer therapy.
reftext: Maryam Shariati, et al. Expert Opin Investig Drugs. ;28(11):977-988.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9642715
figid_alias: PMC6901085__F1
figtype: Figure
redirect_from: /figures/PMC6901085__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6901085__nihms-1541390-f0001.html
  '@type': Dataset
  description: Representation of AKT pathway and downstream effectors. Shown are the
    key molecular targets involved in AKT signaling. Upon growth factor binding to
    receptor tyrosine kinase (RTK), phosphoinositol bisphosphate (PIP2) is converted
    to phosphoinositol trisphosphate (PIP3), which recruits AKT and phosphoinositide-dependent
    kinase-1 (PDK1) to the plasma membrane by binding the PH domain to membrane lipids.
    PDK1 and mammalian target of rapamycin complex 2 (mTORC2) phosphorylate AKT, resulting
    in full activation of AKT. Phosphatase and tensin homolog (PTEN) and PH domain
    leucine-rich-protein phosphatase (PHLPP) negatively regulate AKT through dephosphorylation
    of PIP3 and AKT (serine-473 residue) respectively. Once activated AKT phosphorylates
    and inhibits the proline-rich AKT substrate of 40 kDa (PRAS40) and tuberous sclerosis
    complex 1 and 2 (TSC1 and TSC2) to promote protein synthesis. AKT blocks apoptosis
    through inhibition of BCL-2-antagonist of cell death (BAD), BCL-2-like protein
    11 (BIM), and forkhead box protein O1 (FoxO1). It also phosphorylates MDM2, resulting
    in p53 degradation. AKT prevents cell cycle arrest and cyclin D1 degradation by
    phosphorylating and inhibiting cyclin dependent kinase inhibitor p27, and glycogen
    synthase kinase 3β (GSK3β).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - IRS1
  - GRB2
  - GAB2
  - PHLPP1
  - RHEB
  - RHEBP1
  - MAPKAP1
  - MTOR
  - PTPA
  - THEM4
  - AKT1
  - AKT2
  - AKT3
  - MLST8
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - RICTOR
  - PRR5
  - PDK1
  - PDPK1
  - TSC1
  - CCL26
  - TSC2
  - AKT1S1
  - MDM4
  - MDM2
  - PTEN
  - CDKN2A
  - YWHAQ
  - BAD
  - YAP1
  - GSK3A
  - GSK3B
  - EIF4EBP1
  - TP53
  - TP63
  - TP73
  - ARHGAP24
  - CDKN1B
  - RPS6KB1
  - RPS6KB2
  - EIF4E
  - EIF4E2
  - EIF4E3
  - PDCD4
  - BCL2
  - CCND1
  - IMPG2
  - BCL2L1
  - BAX
  - BCL2L11
  - Irs1
  - Grb2
  - Gab2
  - Phlpp1
  - Rheb
  - Mapkap1
  - Mtor
  - Ppp2ca
  - Ppp2r1a
  - Them4
  - Akt1
  - Mlst8
  - Pik3r1
  - Rictor
  - Prr5
  - Pdk1
  - Pdpk1
  - Tsc1
  - Tsc2
  - Akt1s1
  - Mdm4
  - Mdm2
  - Rptor
  - Pten
  - Sfn
  - Bad
  - Yap1
  - Gsk3b
  - Eif4ebp1
  - Trp53
  - Trp73
  - Iap1
  - Cdkn1b
  - Rps6kb1
  - Eif4e
  - Pdcd4
  - Bcl2
  - Ccnd1
  - Bcl2l1
  - Bax
  - Nkx3-1
  - Bcl2l11
  - drk
  - Phlpp
  - Sin1
  - Tor
  - wrd
  - wdb
  - mts
  - tws
  - Pp2A-29B
  - Akt
  - Lst8
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - rictor
  - gig
  - PRAS40
  - raptor
  - 14-3-3zeta
  - 14-3-3epsilon
  - cass
  - yki
  - sgg
  - Thor
  - p53
  - betaTub60D
  - hth
  - S6k
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - Debcl
  - Cyt-c-d
  - Cyt-c-p
  - CycE
  - cyc
  - Tie
  - Ras85D
  - InR
---
